Sagimet Biosciences

0 followers


Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways.

Industries

Headquarters

Stage

Employees

Links

David Happel
CEO & Director

David Happel

Collapse
Eduardo Bruno Martins
Chief Medical Officer
Elizabeth Rozek
General Counsel & Chief Compliance Officer
Marie O’Farrell
SVP of Research & Development
Katharine Grimmer
Vice President
Wen-Wei Tsai
Director